These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2055655)

  • 21. Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median followup of 30 months.
    Weidner W; Schiefer HG; Brähler E
    J Urol; 1991 Aug; 146(2):350-2. PubMed ID: 1856930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study.
    Weidner W; Schiefer HG; Dalhoff A
    Am J Med; 1987 Apr; 82(4A):280-3. PubMed ID: 3555048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of urine on the in vitro antimicrobial activity of various antibiotics against different Escherichia coli phenotypes.
    Büyükbaba-Boral O; Gönüllü N; Küçükbasmaci O; Anğ-Küçüker M; Anğ O
    Chemotherapy; 2004 Apr; 50(1):35-9. PubMed ID: 15084804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15.
    Delisle G; Quach C; Domingo MC; Boudreault AA; Gourdeau M; Bernatchez H; Lavallée C
    J Antimicrob Chemother; 2016 Dec; 71(12):3562-3567. PubMed ID: 27494927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum antibody titers in treatment with trimethoprim-sulfamethoxazole for chronic prostatitis.
    Meares EM
    Urology; 1978 Feb; 11(2):142-6. PubMed ID: 343344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid.
    Stamey TA; Meares EM; Winningham DG
    J Urol; 1970 Feb; 103(2):187-94. PubMed ID: 4903520
    [No Abstract]   [Full Text] [Related]  

  • 27. A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice.
    Vellinga A; Murphy AW; Hanahoe B; Bennett K; Cormican M
    J Antimicrob Chemother; 2010 Jul; 65(7):1514-20. PubMed ID: 20457673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative therapeutic activities of ciprofloxacin, amoxicillin, ceftriaxone and co-trimoxazole in a new model of experimental infection with Escherichia coli.
    Hof H; Christen A; Hacker J
    Infection; 1986; 14(4):190-4. PubMed ID: 3531024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group.
    Naber KG; Busch W; Focht J
    Int J Antimicrob Agents; 2000 Mar; 14(2):143-9. PubMed ID: 10720805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ciprofloxacin on adhesive properties of non-P mannose-resistant uropathogenic Escherichia coli isolates.
    Balagué C; Fernández L; Pérez J; Grau R
    J Antimicrob Chemother; 2003 Feb; 51(2):401-4. PubMed ID: 12562710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of chronic bacterial prostatitis.
    Pfau A
    Infection; 1991; 19 Suppl 3():S160-4. PubMed ID: 2055653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventive effect of selenium on chronic bacterial prostatitis.
    Kim HW; Ha US; Woo JC; Kim SJ; Yoon BI; Lee SJ; Cho YH
    J Infect Chemother; 2012 Feb; 18(1):30-4. PubMed ID: 21814801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting.
    Gottesman BS; Carmeli Y; Shitrit P; Chowers M
    Clin Infect Dis; 2009 Sep; 49(6):869-75. PubMed ID: 19686074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates.
    Lin CY; Huang SH; Chen TC; Lu PL; Lin WR; Chen YH
    J Microbiol Immunol Infect; 2008 Aug; 41(4):325-31. PubMed ID: 18787740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of trimethoprim-sulfamethoxazole in chronic prostatitis.
    Chesley AE; Dow D
    Urology; 1973 Sep; 2(3):280-2. PubMed ID: 4583821
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
    Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
    Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E. coli Resistance to Ciprofloxacin and Common Associated Factors.
    Jadoon RJ; Jalal-ud-Din M; Khan SA
    J Coll Physicians Surg Pak; 2015 Nov; 25(11):824-7. PubMed ID: 26577970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness model comparing trimethoprim sulfamethoxazole and ciprofloxacin for the treatment of chronic bacterial prostatitis.
    Kurzer E; Kaplan S
    Eur Urol; 2002 Aug; 42(2):163-6. PubMed ID: 12160588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ciprofloxacin treatment of urinary infections results in increased resistance of urinary E. coli to ciprofloxacin and co-trimoxazole.
    Borgmann S; Jakobiak T; Gruber H; Schröder H; Sagel U
    Pol J Microbiol; 2009; 58(4):371-3. PubMed ID: 20380149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trimethoprim and methenamine hippurate. A new theoretical combination for the treatment of urinary tract infections.
    Räisänen S; Ylitalo P; Toponen A; Seppänen J
    Scand J Infect Dis; 1985; 17(2):211-8. PubMed ID: 3895402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.